Illumina to Supply LabCorp with NGS and Microarray Instruments GenomeWeb "The Illumina next-generation sequencing platform gives LabCorp the flexibility to develop a wide range of molecular tests," Mark Brecher, LabCorp's chief medical officer, said in a statement. "The HLA typing assays we are developing on Illumina's ... |
